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We measured alveolar NO concentration, bronchial
NO flux, and levels of 8-isoprostane and LTB4 in exhaled
breath condensate (EBC) in 61 subjects with COPD.
These measurements were repeated in 40 patients after
4 weeks of treatment with inhaled fluticasone (500 μg
b.i.d.).
Subjects with COPD had higher levels of 8-iso-
prostane and LTB4 in EBC, increased alveolar NO
concentration, but decreased bronchial NO flux as
compared with healthy subjects. Bronchial NO flux
correlated positively with β2-agonist-induced change in
FEV1 (r=0.372, p=0.003), but other inflammatory
markers were not related to lung function. Baseline
levels of bronchial NO flux were associated with higher
increase in FEV1/FVC (r=0.313, p=0.049) and better
symptom alleviation during the fluticasone treatment.
In conclusion, high bronchial NO flux in COPD predicts
favourable acute response to β2-agonists and a good
response also to treatment with ICS. The other tested
markers are not related to disease severity or treatment
responses in COPD.
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Vascular endothelial growth factor (VEGF) is involved in
lung development, angiogenesis and in response to
injury. Chronic obstructive pulmonary disease (COPD) is
an inflammatory disease characterised by accumulation
of T-cells and remodelling of the airways. We
hypothesized that T-cell secreted VEGF is modulated by
cigarette-smoke and by a hypoxic microenvironment
and that these conditions have an impact on protein
secretion from T-cells from patients with COPD.
T-cells were isolated from peripheral blood of
healthy donors and stimulated in normoxia and hypoxia
with or without exposure to cigarette smoke extract
(CE). VEGF and selected cytokines were measured in
T-cell conditioned media (CBA flex set and ELISA).
Hypoxia (1-2% O2) stimulated VEGF secretion from T-
cells, whereas the release of inflammatory cytokines
(IL-4, IL-6, IL-10, IL-13, IFN-γ and TNF) were not
affected. CE did not influence VEGF secretion neither in
hypoxia nor in normoxia whereas cytokine secretion was
inhibited by CE in both conditions. T-cells from COPD-
patients (FEV1 23-63 % of predicted) secreted
significantly more VEGF compared to T-cells from age-
matched healthy individuals.
The persistent VEGF secretion despite an inhibition
of other T-cell secreted mediators by CE suggests that
VEGF may act as a modulating factor in a hypoxic
microenvironment in COPD. This hypothesis is supported
by elevated VEGF levels from stimulated T-cells from
COPD patients.
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Type I and III collagen protein precursors are increased
in fibrosing processes in the lung. The aim of this study
was to compare the expression of these precursor
proteins in the small airways of nonsmokers, smokers
and COPD-patients with different severity of the
disease, as a marker of newly formed fibrosis.
Procollagen I and III aminoterminal peptides (PINP
and PIIINP) were studied by immunohistochemistry in
lung tissue of 16 life-long non-smokers, 20 current
smokers with normal lung function and 20 current
smokers with COPD. Tissue specimens from tumor-free
peripheral lung tissue were selected. COPD was defined
according to GOLD criteria.
No expression of PINP was found in the subepithelial
layer of small bronchioli. In peripheral bronchioli the
PIIINP expressing layer was thickest in stage I-II COPD
and thinnest in severe COPD (p=0.015). Western blotting
of the total lung homogenates showed a higher level of
PIIINP in nonsmokers compared to smoker groups.
In small airways, PIIINP expression increases in mild-
moderate COPD but decreases at end-state disease, as a
marker of cessation of active fibrogenesis. However, the
total lung homogenate shows decreased expression of
PIIINP in all smoker groups, referring to the possibility of
balance shift towards degradation in other lung
compartments.
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Background: It has been proposed that COPD is an
independent predictor of cardiovascular disease (CVD).
Arterial stiffness has been shown to predict CVD and
aortic augmentation index (AIx) is an easily obtained
measure of arterial wave reflection – that can be used
as a surrogate measure of arterial stiffness.
Objective: To examine the association between COPD
and lung function (FEV1, FVC) in general, and arterial
stiffness measured by AIx in a cohort of the Danish
population.
Methods: This population-study is based on 6300
subjects from the Copenhagen City Heart Study where
869 met the diagnostic criteria for COPD according to
GOLD. We looked at the crude association between AIx
corrected for heart rate (AIx75) and COPD as well as the
severity of COPD stratified by gender. Using multivariate
linear regression we examined the association between
AIx75 and COPD (moderate to severe) adjusted for age,
age squared, height and weight, factors known to be
associated with AIx75. We also looked at the effect of
COPD on AIx75 in a model fully adjusted for
cardiovascular risk factors.
Results: The crude analysis showed that AIx75 was
significantly increased in subjects with COPD and that
AIx75 increased with increasing severity of COPD
according to GOLD. After adjusting for age, age2, height
and weight the effect of COPD was marginally
significant in men, but not in women. In the model fully
adjusted for CVD risk factors there was no effect of
COPD on AIx75. In men, there was a significant
association between FEV1 as a continuous variable and
AIx75 in the model fully adjusted for CVD risk factors;
however, this was equally strong for FVC and not seen in
women.
Conclusions: Our findings question the role of COPD as
an independent risk factor for arterial stiffness and thus
for cardiovascular disease.
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Recent reports have shown an association between
periodontitis and chronic obstructive pulmonary disease
(COPD). Our objective was to assess if COPD status
affects the subgingival microflora based on culture-
independent methods. Eighteen subjects were classified
into four different groups according to clinical perio-
dontal status and to the airway obstruction after lung
function testing. DNA from subgingival plaque samples
was extracted and the bacterial 16S rRNA genes were
PCR amplified, cloned, and sequenced to determine
species identity. From a total of 1,041 clones, 168
species or phylotypes were detected. Species of
Granulicatella and Streptococcus were associated with
a healthy periodontium in both COPD and non-COPD
subjects. In the healthy subgingival microflora of COPD
subjects, higher amounts of Actinomyces spp.,
Veillonella spp. and Campylobacter gracilis were
detected as compared to healthy controls. COPD status
was found to have little influence on the subgingival
microflora in periodontitis subjects. In conclusion, COPD
status does seem to influence the healthy, but not the
diseased subgingival microflora in periodontitis. These
findings indicate that there may be host factors
responsible for the increased susceptibility of COPD
subjects to periodontal disease. The periodontal pocket
of COPD subjects was not found to be a reservoir for
recognized pulmonary pathogens.
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Aims: Patients suffering from chronic obstructive
pulmonary disease with alveolar hypoxia can also have
diastolic dysfunction in the right and left ventricle (LV).
In an experimental model we have shown that the LV
diastolic dysfunction may be caused by altered
phosphorylation of the calcium handling protein
phospholamban at serine (Ser) 16 in the myocardium.
The mechanisms leading to changes in phosphorylation
of phospholamban are explored.
Methods: In mice exposed to 10% oxygen, phosphatases
and signaling molecules were measured in cardiac tissue
and serum. Cardiomyocytes isolated from mice were
exposed to hypoxia-induced cytokines for 24 hours.
S6 M. Sköld et al.
